AstraZeneca PLC
About AstraZeneca
AstraZeneca PLC is a global biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of prescription medicines across various therapy areas.
The company's product portfolio includes:
-
Oncology: Medications like Calquence, Enhertu, Faslodex, Imfinzi, Lynparza, Tagrisso, and Zoladex.
-
Cardiovascular, Renal, and Metabolism: Products such as Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR
-
Respiratory and Immunology: Treatments including Bevespi/Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris
-
Rare Diseases: Medications like Andexxa/Ondexxya, Soliris, Strensiq, and Ultomiris.
-
Other Areas: The company's marketed products also comprise Synagis for respiratory syncytial virus, Fluenz Tetra/FluMist Quadrivalent for Influenza, Seroquel IR/Seroquel XR for schizophrenia bipolar disease, Nexium, and Losec/Prilosec for gastroenterology, Vaxzevria and Evusheld for covid-19.
AstraZeneca serves healthcare providers through a combination of distributors and local representative offices, covering the United Kingdom, Europe, the Americas, Asia, Africa, and Australasia.
The company collaborates with industry leaders like Regeneron Pharmaceuticals, Neurimmune AG, Ionis Pharmaceuticals, Proteros Biostructures GmbH, and Sierra Oncology, Inc., to expand its research and development capabilities.
Originally known as Zeneca Group PLC, the company changed its name to AstraZeneca PLC in 1999 following a merger.
AstraZeneca was incorporated in 1992 and is headquartered in Cambridge, United Kingdom.
AstraZeneca's Business Strategy
AstraZeneca operates a focused, science-led business model centered on the discovery, development, and commercialization of innovative medicines. The company concentrates on three core therapeutic areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology), and Rare Diseases. This strategic focus enables AstraZeneca to…
Available on Finplify
Free account required
Our Take on AstraZeneca
Pros:
✅ High-Quality, Innovation-Driven Portfolio: AstraZeneca has successfully repositioned itself as a science-led biopharmaceutical company, with leadership in oncology, cardiovascular, renal, respiratory, and rare diseases. The company’s focus on biologics and precision medicine has fueled sustained growth.
✅ Deep Pipeline: AstraZeneca has built one of the…
Available on Finplify
Free account required
Company Details
Key Metrics
Fundamental Analysis
Proprietary 5-category scoring system
Score Fingerprint
Section Scores
Full Breakdown & Peer Ranking
See the detailed score for every metric and how this stock ranks against its sector peers
Unlock the full research on AstraZeneca
Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.
300+ Curated Stocks
A hand-picked universe of world-class businesses across every major market and sector.
AI Analyst Briefings
Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.
Proprietary Fundamentals
Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.